No Data
Hong Kong Stock Announcement | HENLIUS: The phase 3 clinical study of the recombinant anti-VEGF humanized monoclonal antibody injection HLX04-O for the treatment of wet age-related macular degeneration (wAMD) has reached its primary study endpoint.
CHINA NEWCITY (01321) collaborates with CITIC Capital to establish a joint platform to explore new opportunities in urban renewal and distressed asset investment; IMMUNEONCO-B (01541) has had its application for clinical trials of IMC-003/IMM72 for treating pulmonary arterial hypertension (PAH) accepted by the National Medical Products Administration.
Express News | King's Stone - Mandatory Unconditional Cash Offer by Offeror to Acquire All Issued Shares of King's Stone
Jinshi Holdings Group (01943) Shareholders will transfer Stocks from China Merchants International Securities to Astron Capital Management, with a Market Cap of 73.5666 million Hong Kong dollars.
On March 20, shareholders of Kingsstone Holdings Group (01943) transferred Stocks from China Merchants International Securities to Astral Capital Management, with a Market Cap of 73.5666 million Hong Kong dollars, accounting for 75.07%.
King's Stone Holdings Announces Trading Halt Amid Inside Information Disclosure
Jinshi Holdings Group (01943.HK) was briefly suspended from trading this morning.
Gelonghui March 20丨Goldstone Holdings Group (01943.HK) announced that trading of its shares will be temporarily suspended from 9:00 AM today (20/3/2025).
Express News | King's Stone - Shares of Co on Stock Exchange of Hong Kong Halted With Effect From 9:00 A.m. on 20 March
